Fig. 2From: α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathwaysEffect of ALA and TRAS, alone and in combination, on the expression of total and phosphorylated HER2, Akt and MAPK after 48 and 96 h of treatment of BT-474 cells. (n = 5-6). Representative blots are displayedBack to article page